Profectus BioSciences is an innovative clinical stage vaccine company devoted to preventing and treating viral diseases and malaria through the application of its proprietary pDNA and rVSV platform. The Company’s name, Profectus, when translated from its Latin roots, means “to advance or improve,” thus capturing the Company’s approach to advance products that improve the health of patients suffering from viral diseases and malaria. The Company’s vaccine targets include HCV, HPV, HSV, HIV, and malaria. To learn more, please visit us at www.profectusbiosciences.net